Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05PGM
|
|||
| Former ID |
DIB006295
|
|||
| Drug Name |
AdV-tK
|
|||
| Indication | Ankylosing spondylitis [ICD-11: FA92.0; ICD-10: M45; ICD-9: 720] | Phase 2 | [1] | |
| Company |
Advantagene
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00589875) Phase 2a Study of AdV-tk With Standard Radiation Therapy for Malignant Glioma (BrTK02). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.